Prospective randomized trial for optimizing medical therapy after coronary stenitng
Not Applicable
- Conditions
- Coronary artery disease (CAD)
- Registration Number
- JPRN-UMIN000008321
- Lead Sponsor
- Keio University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Stent restenosis or previous bypass surgery. 2.Previous diagnosis of vasospasmic angina within 1 years and/or on treatment. 3.Previous PCI within 1 years. 4.An event of acute myocardial infarction within 7 days. 5.Left main disease. 6.Left ventricular ejection fraction of less than 35%. 7.Previous Pacemaker Implant or AV block of more than 1st degree. 8.SBP less than 100 or HR less than 60 prior to PCI. 9.Renal failure (Cr more than 2.0mg/dl or on hemodialysis) 10.Liver failure (eg. cirrhosis) 11.Reversible obstructive lung disease 12.Diagnosis of malignancy within 5 years 13.Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence of Acetylcholine induced coronary vasospasm 9 month after PCI
- Secondary Outcome Measures
Name Time Method All cause death MACEE: acute myocardial infarction, stable or unstable angina, any coronary revascularization procedure, or cerebrovascular accident